Thyroid eye disease occurs when the same autoimmune process affecting your thyroid gland (most commonly Graves’ disease) also attacks the tissue around your eyes, causing inflammation, swelling of the eye muscles and fat, and in some cases bulging (proptosis), double vision, or pressure on the optic nerve. It can occur even if your thyroid levels are currently normal, and it needs a coordinated eye and endocrine assessment rather than eye drops alone.
Thyroid Eye Disease: Why Your Eyes Are Affected When It’s Your Thyroid
Most people are surprised the first time I tell them their eye problem is coming from their thyroid. They came in because their eyes felt gritty, looked more prominent than before, or because a friend mentioned they seemed to be “staring.” Very few connect that to a gland in the neck.
But thyroid eye disease, also called TED or Graves’ orbitopathy, is one of the more common reasons adults develop new eye swelling, bulging, or double vision after the age of 30. It happens when the immune system, already active against the thyroid gland, starts attacking the muscles and fat behind the eyes as well.
In this article, I’ll walk you through what causes it, the symptoms to watch for, when it becomes urgent, and what treatment actually looks like today, because TED is very different to manage now compared to even ten years ago.
Common Symptoms and What They Mean
| Symptom | What It Means | What To Do About It |
|---|---|---|
| Eyes look more prominent or “staring” | Swelling of the fat and muscles behind the eye is pushing the eyeball forward (proptosis) | Get an orbital assessment; this is a hallmark early sign and worth documenting with photos to track progression |
| Upper eyelid sits higher than normal, showing white above the iris | Eyelid retraction from overactive muscle tone, common in active TED | See an ophthalmologist; this can also affect blink and corneal protection |
| Gritty, dry, burning eyes | Reduced blinking and incomplete lid closure from retraction expose the cornea to air | Start preservative-free lubricating drops and gel at night; get evaluated if it doesn’t improve in a week |
| Double vision, especially looking up or sideways | Swollen eye muscles are restricting movement of one or both eyes | See a neuro-ophthalmologist promptly; this needs muscle assessment, not just glasses |
| Puffy, swollen eyelids, worse in the morning | Fluid and inflammation in the orbital tissue | Track whether it’s one-sided or both sides, and how quickly it’s changing; report new swelling within days |
| Redness or a pink tinge over the white of the eye | Inflamed blood vessels from active orbital inflammation | This is a sign of active (not stable) disease; needs assessment for anti-inflammatory treatment |
| Pain behind the eyes or with eye movement | Active inflammation of the orbital muscles and fat | Flag this to your doctor immediately, it usually indicates the active inflammatory phase requiring treatment |
| Blurred or dimming vision, especially colour appearing washed out | Possible optic nerve compression from swollen muscles at the back of the orbit | This is an emergency; needs same-week evaluation to prevent permanent vision loss |
When To See a Doctor
- Any new one-sided bulging or swelling of a single eye
- Pain, redness, or warmth around the eye, especially if it’s worsening
- New or worsening double vision
- Any blurring, dimming, or colour desaturation of vision, this needs urgent same-week assessment for optic nerve involvement
- Visible proptosis (the eye appearing pushed forward) that is new or increasing
- Inability to fully close the eyelids, especially during sleep
- If you already have a thyroid diagnosis and notice any eye changes, even mild ones
- Rapid progression of any of the above over days to a few weeks
Important: TED can occur before, during, or after your thyroid levels are treated, and sometimes even when your thyroid blood tests are entirely normal. Don’t rule out TED just because your endocrinologist says your thyroid numbers look fine.
Home Measures
- Preservative-free artificial tears during the day, and lubricating gel or ointment at night if the eyes don’t close fully
- Sleep with the head slightly elevated to reduce overnight fluid pooling around the eyes
- Cold compresses in the morning can reduce lid puffiness, but should not replace medical evaluation
- Stop smoking, this is not a general wellness tip here; smoking is the single strongest modifiable risk factor for both developing TED and for it progressing to severe disease
- Wraparound sunglasses outdoors, since TED often increases light sensitivity and wind exposure worsens dryness
Medical & Treatment Options
During the active inflammatory phase
This phase typically lasts 6 months to 2 years. Treatment here focuses on controlling inflammation before it causes permanent changes:
- Intravenous or oral corticosteroids for moderate to severe active inflammation
- Newer targeted biologic therapy (teprotumumab, where available) for significant proptosis or moderate-to-severe active disease
- Orbital radiotherapy in select cases, usually combined with steroids
- Close coordination with your endocrinologist to stabilise thyroid hormone levels, since both hyperthyroidism and hypothyroidism can worsen eye disease
During the stable (inactive) phase
Once inflammation has settled, any residual bulging, double vision, or lid position problems are usually addressed surgically, in a specific order:
- Orbital decompression surgery, if there is significant proptosis or optic nerve compression
- Eye muscle surgery, to correct persistent double vision
- Eyelid surgery, to correct retraction or reposition the lids
For sight-threatening compression
If the optic nerve is being compressed, this is treated urgently with high-dose steroids and, if needed, emergency decompression surgery to prevent permanent vision loss.
A Note on Glaucoma Risk
Thyroid eye disease can also raise eye pressure. As the swollen muscles and fat crowd the orbit, they can restrict normal fluid drainage from the eye, especially when looking upward, and push pressure readings higher than they’d otherwise be. This is easy to miss because the focus is usually on appearance or double vision, not pressure. If you have TED, ask specifically for an intraocular pressure check at each visit, particularly if you also have a family history of glaucoma. [Learn more about glaucoma risk factors →]
A Note on Dry Eye
Dry eye is almost universal in thyroid eye disease, not just a side effect of irritation. Eyelid retraction and reduced blinking mean more of the eye surface is exposed to air for longer, so tears evaporate faster than they can be replenished. This is why lubrication needs to be more frequent and more deliberate than for ordinary dry eye, preservative-free drops through the day and a thicker gel or ointment at night, even before any other treatment for TED begins. [Learn more about managing dry eye →]
Frequently Asked Questions
Can thyroid eye disease happen without a thyroid diagnosis?
Yes. In a small proportion of patients, TED symptoms appear before any thyroid abnormality is detected on blood tests. If you develop unexplained eye bulging, lid retraction, or double vision, ask specifically to be screened for thyroid antibodies, even if you feel otherwise well.
Does treating my thyroid levels also treat my eyes?
Not necessarily. Thyroid hormone levels and eye disease activity are related but don’t always move together. Some patients develop or worsen TED even after their thyroid levels are normalised with medication. Eye disease usually needs its own separate treatment plan.
Will my eyes go back to normal?
It depends on severity and how early treatment starts. Mild cases often improve significantly once the active phase settles. Moderate to severe cases, especially with significant proptosis or muscle involvement, usually need surgical correction after the inflammation stabilises to restore appearance and function.
Is thyroid eye disease the same as Graves’ disease?
Not exactly. Graves’ disease is the autoimmune thyroid condition; thyroid eye disease is the eye manifestation that can accompany it. About 25 to 30 percent of people with Graves’ disease develop clinically significant eye involvement, though milder eye changes are more common.
Why does smoking make it worse?
Smoking increases orbital tissue inflammation and has been consistently shown to increase both the risk of developing TED and the severity of disease. It also reduces how well certain treatments work. Quitting is one of the few changes patients can make that measurably affects outcomes.
How urgent is it if I have double vision but no pain?
Painless double vision still needs prompt evaluation. It usually indicates that the eye muscles are already swollen enough to restrict movement, which is a sign of active disease needing assessment, even without pain or visible bulging.
Key Takeaways
- Thyroid eye disease is an autoimmune condition affecting the muscles and fat around the eyes, most often linked to Graves’ disease
- It can occur even when thyroid blood tests are normal
- Early signs include lid retraction, eye prominence, dryness, and puffiness
- Double vision, pain, or vision changes need urgent specialist assessment
- Smoking is the strongest modifiable risk factor, quitting matters clinically, not just generally
- Treatment differs by phase: anti-inflammatory control during active disease, surgical correction once stable
Book a Consultation
If you’ve noticed changes in how your eyes look or work, especially alongside a thyroid diagnosis, it’s worth getting a proper orbital and neuro-ophthalmic assessment rather than waiting to “see if it settles.” Early evaluation during the active phase gives us the most options to prevent permanent changes.
I coordinate closely with endocrinology colleagues to manage thyroid eye disease from both ends, the gland and the eyes, together.
[Book an Appointment → contact us | 8882638735]
About the Author
This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.
She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.
As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.
1600+ Five Star Patient Reviews Google Business Profile
If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation
Read her research on PubMed | Google Scholar | ResearchGate | ORCID
Upload your reports for a structured review.| www.drshibalbhartiya.com | +91 88826 38735
Leave a review on Google
